Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/11/2025

Best Anxiety Medication for Individuals with a History of Substance Abuse

Primary Recommendation: SSRIs

  • The American Academy of Neuropsychopharmacology recommends SSRIs as effective first-line treatments for anxiety disorders with strong evidence supporting their use 1
  • SSRIs including escitalopram, sertraline, paroxetine, and fluvoxamine have demonstrated efficacy for anxiety without risk of physical dependence or abuse 1

Alternative First-Line Option: SNRIs

  • Venlafaxine (an SNRI) is recommended as a first-line treatment with efficacy comparable to SSRIs and similar tolerability profiles 1
  • SNRIs have dropout rates similar to placebo, suggesting good tolerability without abuse concerns 1

What to Absolutely Avoid

  • The Centers for Disease Control and Prevention warns that benzodiazepines should be avoided when possible, especially in patients with a history of substance abuse 1
  • The NCCN guidelines note that substance abuse developed during treatment may result from insufficient symptom control, but if a history of substance abuse is present, patients should be referred to risk reduction or substance management programs rather than prescribed benzodiazepines 2
  • When patients are already on benzodiazepines, a gradual taper is essential when switching to alternative treatments to avoid withdrawal symptoms 1

Additional Considerations

  • Beta-blockers (propranolol) can be used for performance anxiety and physical symptoms of anxiety without abuse risk 1
  • Alpha-2 adrenergic agonists (clonidine, guanfacine) can help with anxiety when there's autonomic hyperarousal component 1

Treatment Approach

  • Cognitive Behavioral Therapy (CBT) is highly effective for anxiety disorders and should be considered in combination with medication for optimal outcomes 1

Clinical Monitoring

  • If anxiety responds to initial treatment, follow-up with the primary care team is appropriate; if no response occurs, reevaluate and consider different medication classes rather than escalating doses 2

REFERENCES

1

Non-Benzodiazepine Medications for Anxiety [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

distress management. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010